Healthy Choice Wellness (HCWC) CFO awarded 400,000 restricted Class A shares

Q: What insider transaction did HCWC disclose in this Form 4?

The filing shows that Director and Chief Financial Officer John Ollet reported ownership of 378,177 shares of Class A common stock and a new grant of 400,000 restricted shares of Class A common stock as a derivative security.

Q: How many HCWC restricted shares were granted to John Ollet and at what price?

John Ollet received 400,000 restricted shares of Class A common stock with a conversion or exercise price of $0, according to the derivative securities table.

Q: When do John Ollet’s HCWC restricted shares start vesting and when are they fully vested?

The restricted stock begins vesting on February 13, 2026 and then vests quarterly on each May 13, August 13, and November 13, becoming fully vested on November 13, 2027 .

Q: How are the HCWC restricted shares vesting structured for John Ollet?

The award vests in eight equal quarterly installments , with each installment vesting on specified dates from 02/13/2026 through 11/13/2027, as described in the explanation of responses.

Q: Does the HCWC restricted stock grant to John Ollet have change of control protection?

Yes. The filing states that the restricted stock will immediately vest upon certain change of control events described in John Ollet’s Restricted Stock Award Agreement.

Q: What is John Ollet’s role at Healthy Choice Wellness Corp. (HCWC)?

John Ollet is identified as both a Director and an Officer , serving as the company’s Chief Financial Officer .

Q: How many derivative securities in HCWC does John Ollet own after this transaction?

Following the reported grant, John Ollet beneficially owns 400,000 derivative securities in the form of restricted shares of Class A common stock, held directly.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Healthy Choice Wellness Corp. reported an equity award to a senior executive. Director and Chief Financial Officer John Ollet reported holdings of 378,177 shares of Class A common stock held directly. In addition, he was granted 400,000 restricted shares of Class A common stock as a derivative security at an exercise price of $0 on 11/13/2025, bringing his total derivative holdings to 400,000.

The restricted stock is scheduled to vest in eight equal quarterly installments, starting on 02/13/2026 and continuing on each May 13, August 13, and November 13 until fully vested on 11/13/2027. The award agreement also provides for immediate vesting if certain change of control events occur, as defined in the reporting person’s Restricted Stock Award Agreement.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Ollet John

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Class A Common Stock	--	--	--
Grant/Award	Class A Common Stock	400,000	$0.00	--

Holdings After Transaction: Class A Common Stock — 378,177 shares (Direct)

Footnotes (1)

[object Object]

Form 4 Insider Transactions: What Each Field Means →

12/02/2025 - 09:56 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ollet John

(Last)

(First)

(Middle)

3800 NORTH 28TH WAY, UNIT 1

(Street)

HOLLYWOOD

33020

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHY CHOICE WELLNESS CORP. [ HCWC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock								378,177	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	$0	11/13/2025		A		400,000		⁽¹⁾	⁽¹⁾	Class A Common Stock	400,000	$0	400,000	D

Explanation of Responses:

1. The Restricted Stock vests in eight equal quarterly installments, commencing on February 13, 2026 and continuing to vest on each subsequent May 13, August 13 and November 13 until fully vested on November 13, 2027. The Restricted Stock will immediately vest upon the occurrence of certain change of control events set forth in the Reporting Person's Restricted Stock Award Agreement.

	/s/ Martin Schrier, as Attorney-in-Fact for John Ollet	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did HCWC disclose in this Form 4?

The filing shows that Director and Chief Financial Officer John Ollet reported ownership of 378,177 shares of Class A common stock and a new grant of 400,000 restricted shares of Class A common stock as a derivative security.

How many HCWC restricted shares were granted to John Ollet and at what price?

John Ollet received 400,000 restricted shares of Class A common stock with a conversion or exercise price of $0, according to the derivative securities table.

When do John Ollet’s HCWC restricted shares start vesting and when are they fully vested?

The restricted stock begins vesting on February 13, 2026 and then vests quarterly on each May 13, August 13, and November 13, becoming fully vested on November 13, 2027.

How are the HCWC restricted shares vesting structured for John Ollet?

The award vests in eight equal quarterly installments, with each installment vesting on specified dates from 02/13/2026 through 11/13/2027, as described in the explanation of responses.

Does the HCWC restricted stock grant to John Ollet have change of control protection?

Yes. The filing states that the restricted stock will immediately vest upon certain change of control events described in John Ollet’s Restricted Stock Award Agreement.

What is John Ollet’s role at Healthy Choice Wellness Corp. (HCWC)?

John Ollet is identified as both a Director and an Officer, serving as the company’s Chief Financial Officer.

How many derivative securities in HCWC does John Ollet own after this transaction?

Following the reported grant, John Ollet beneficially owns 400,000 derivative securities in the form of restricted shares of Class A common stock, held directly.